全文获取类型
收费全文 | 149932篇 |
免费 | 10465篇 |
国内免费 | 761篇 |
专业分类
耳鼻咽喉 | 1411篇 |
儿科学 | 3859篇 |
妇产科学 | 2741篇 |
基础医学 | 20014篇 |
口腔科学 | 3450篇 |
临床医学 | 14530篇 |
内科学 | 32064篇 |
皮肤病学 | 2874篇 |
神经病学 | 14525篇 |
特种医学 | 6100篇 |
外国民族医学 | 6篇 |
外科学 | 22856篇 |
综合类 | 1889篇 |
现状与发展 | 2篇 |
一般理论 | 139篇 |
预防医学 | 10752篇 |
眼科学 | 3176篇 |
药学 | 10434篇 |
中国医学 | 245篇 |
肿瘤学 | 10091篇 |
出版年
2023年 | 744篇 |
2022年 | 492篇 |
2021年 | 2529篇 |
2020年 | 1960篇 |
2019年 | 2818篇 |
2018年 | 3429篇 |
2017年 | 2666篇 |
2016年 | 3048篇 |
2015年 | 3517篇 |
2014年 | 5035篇 |
2013年 | 6801篇 |
2012年 | 10520篇 |
2011年 | 11143篇 |
2010年 | 6351篇 |
2009年 | 6045篇 |
2008年 | 10201篇 |
2007年 | 10878篇 |
2006年 | 10348篇 |
2005年 | 10596篇 |
2004年 | 10002篇 |
2003年 | 9485篇 |
2002年 | 8860篇 |
2001年 | 1453篇 |
2000年 | 1044篇 |
1999年 | 1442篇 |
1998年 | 1751篇 |
1997年 | 1361篇 |
1996年 | 1119篇 |
1995年 | 1250篇 |
1994年 | 1105篇 |
1993年 | 1077篇 |
1992年 | 752篇 |
1991年 | 774篇 |
1990年 | 602篇 |
1989年 | 583篇 |
1988年 | 543篇 |
1987年 | 557篇 |
1986年 | 493篇 |
1985年 | 525篇 |
1984年 | 620篇 |
1983年 | 547篇 |
1982年 | 751篇 |
1981年 | 686篇 |
1980年 | 587篇 |
1979年 | 350篇 |
1978年 | 363篇 |
1977年 | 390篇 |
1976年 | 325篇 |
1975年 | 283篇 |
1974年 | 249篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Peter J. Hordyk Brent A. Fuerbringer Thomas S. Roukis 《The Journal of foot and ankle surgery》2018,57(3):521-526
The most common reason for a revision total ankle replacement procedure is a painful, stiff ankle even after the initial surgery. Limited and conflicting data are available regarding the change in sagittal foot and ankle range of motion after revision total ankle replacement surgery. We sought to determine whether revision total ankle replacements would reduce compensatory midfoot range of motion. In determining this, a novel radiographic measurement system with stable osseous landmarks is used. A retrospective medical record review of patients who had undergone revision total ankle replacement from January 2009 to June 2016 was performed. Thirty-three patients (33 ankles) underwent revision total ankle replacement surgery and met the inclusion criteria with a mean follow-up period of 28.39?±?14.68 (range 2 to 59) months. Investigation of preoperative and postoperative weightbearing lateral radiographic images was performed to determine the global foot and ankle, isolated ankle, and isolated midfoot sagittal ranges of motion. Statistical analysis revealed a significant increase in ankle range of motion (p = .046) and a significant decrease in midfoot range of motion (p < .001) from preoperatively to postoperatively. The change in global foot and ankle range of motion was not significant (p = .53). For this patient population, the increased ankle range of motion effectively resulted in less compensatory midfoot range of motion. 相似文献
992.
Andrea A. Hayes-Jordan Brian A. Coakley Holly L. Green LianChun Xiao Keith F. Fournier Cynthia E. Herzog Joseph A. Ludwig Mary F. McAleer Peter M. Anderson Winston W. Huh 《Annals of surgical oncology》2018,25(4):872-877
Background
Desmoplastic small round cell tumor (DSRCT) is a rare sarcoma that primarily affects adolescents and young adults. Patients can present with many peritoneal implants. We conducted a phase 2 clinical trial utilizing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) with cisplatin for DSRCT and pediatric-type abdominal sarcomas.Patients and Methods
A prospective cohort study was performed on 20 patients, who underwent CRS-HIPEC procedures, with cisplatin from 2012 to 2013. All patients were enrolled in the phase 2 clinical trial. Patients with extraabdominal disease and in whom complete cytoreduction (CCR0–1) could not be achieved were excluded. All outcomes were recorded.Results
Fourteen patients had DSRCT, while five patients had other sarcomas. One patient had repeat HIPEC. Patients with DSRCT had significantly longer median overall survival after surgery than patients with other tumors (44.3 vs. 12.5 months, p = 0.0013). The 3-year overall survival from time of diagnosis for DSRCT patients was 79 %. Estimated median recurrence-free survival (RFS) was 14.0 months. However, RFS for patients with DSRCT was significantly longer than for non-DSRCT patients (14.9 vs. 4.5 months, p = 0.0012). Among DSRCT patients, those without hepatic or portal metastases had longer median RFS than those with tumors at these sites (37.9 vs. 14.3 months, p = 0.02). In 100 % of patients without hepatic or portal metastasis, there was no peritoneal disease recurrence after CRS-HIPEC.Conclusions
Complete CRS-HIPEC with cisplatin is effective in select DSRCT patients. DSRCT patients with hepatic or portal metastasis have poorer outcomes.993.
John M. Creasy Eran Sadot Bas Groot Koerkamp Joanne F. Chou Mithat Gonen Nancy E. Kemeny Leonard B. Saltz Vinod P. Balachandran T. Peter Kingham Ronald P. DeMatteo Peter J. Allen William R. Jarnagin Michael I. D’Angelica 《Annals of surgical oncology》2018,25(2):431-438
Background
The impact of primary tumor location on overall survival (OS), recurrence-free survival (RFS), and long-term outcomes has not been well established in patients undergoing potentially curative resection of colorectal liver metastases (CRLM).Methods
A single-institution database was queried for initial resections for CRLM 1992–2004. Primary tumor location determined by chart review (right = cecum to transverse; left = splenic flexure to sigmoid). Rectal cancer (distal 16 cm), multiple primaries, and unknown location were excluded. Kaplan–Meier and Cox regression methods were used. Cure was defined as actual 10-year survival with either no recurrence or resected recurrence with at least 3 years of disease-free follow-up.Results
A total of 907 patients were included with a median follow-up of 11 years; 578 patients (64%) had left-sided and 329 (36%) right-sided primaries. Median OS for patients with a left-sided primary was 5.2 years (95% confidence interval [CI] 4.6–6.0) versus 3.6 years (95% CI 3.2–4.2) for right-sided (p = 0.004). On multivariable analysis, the hazard ratio for right-sided tumors was 1.22 (95% CI 1.02–1.45, p = 0.028) after adjusting for common clinicopathologic factors. Median RFS was marginally different stratified by primary location (1.3 vs. 1.7 years; p = 0.065). On multivariable analysis, location of primary was not significantly associated with RFS (p = 0.105). Observed cure rates were 22% for left-sided and 20% for right-sided tumors.Conclusions
Among patients undergoing resection of CRLM, left-sided primary tumors were associated with improved median OS. However, long-term survival and recurrence-free survival were not significantly different stratified by primary location. Patients with left-sided primary tumors displayed a prolonged clinical course suggestive of more indolent biology.994.
1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility Study
Marc D. Moncrieff David Gyorki Robyn Saw Andrew J. Spillane Howard Peach Deemesh Oudit Jenny Geh Peter Dziewulski Ewan Wilson Paolo Matteucci Rowan Pritchard-Jones Roger Olofsson Bagge Frances C. Wright Nic Crampton Oliver Cassell Navid Jallali Adam Berger John Kelly Stephen Hamilton Amer Durrani Serigne Lo Elizabeth Paton Michael A. Henderson 《Annals of surgical oncology》2018,25(9):2541-2549
Background
There is a lack of consensus regarding optimal surgical excision margins for primary cutaneous melanoma?>?1 mm in Breslow thickness (BT). A narrower surgical margin is expected to be associated with lower morbidity, improved quality of life (QoL), and reduced cost. We report the results of a pilot international study (MelMarT) comparing a 1 versus 2-cm surgical margin for patients with primary melanoma?>?1 mm in BT.Methods
This phase III, multicentre trial [NCT02385214] administered by the Australia & New Zealand Medical Trials Group (ANZMTG 03.12) randomised patients with a primary cutaneous melanoma?>?1 mm in BT to a 1 versus 2-cm wide excision margin to be performed with sentinel lymph node biopsy. Surgical closure technique was at the discretion of the treating surgeon. Patients’ QoL was measured (FACT-M questionnaire) at baseline, 3, 6, and 12 months after randomisation.Results
Between January 2015 and June 2016, 400 patients were randomised from 17 centres in 5 countries. A total of 377 patients were available for analysis. Primary melanomas were located on the trunk (56.9%), extremities (35.6%), and head and neck (7.4%). More patients in the 2-cm margin group required reconstruction (34.9 vs. 13.6%; p?<?0.0001). There was an increased wound necrosis rate in the 2-cm arm (0.5 vs. 3.6%; p?=?0.036). After 12 months’ follow-up, no differences were noted in QoL between groups.Discussion
This pilot study demonstrates the feasibility of a large international RCT to provide a definitive answer to the optimal excision margin for patients with intermediate- to high-risk primary cutaneous melanoma.995.
996.
997.
Ioannis Karampinis Michael Keese Jens Jakob Vytautas Stasiunaitis Andreas Gerken Ulrike Attenberger Stefan Post Peter Kienle Kai Nowak 《Journal of gastrointestinal surgery》2018,22(12):2117-2124
Purpose
Surgical exploration and bowel resection are frequently required for treating non-occlusive mesenteric ischemia. Intraoperative evaluation of intestinal perfusion is subjective and challenging. In this feasibility study, ICG fluorescence angiography was performed in order to evaluate intestinal perfusion in patients with acute mesenteric ischemia.Methods
This is a retrospective analysis of 52 patients who were operated for acute mesenteric ischemia using ICG fluorescence angiography. Patients with occlusive disease requiring recanalization were excluded. The SPY and PinPoint imaging systems were used for open and laparoscopic surgery, respectively. Intraoperative macroscopic assessment of perfusion was compared with the ICG angiography results.Results
Surgical exploration was performed for ischemia of the colon (n?=?12), the small bowel (n?=?23), or both (n?=?16). One patient had ischemia of the esophagus and stomach. All patients had a preoperative CT angiography to rule out stenosis or occlusion of the mesenteric vessels. In 18 cases (34.6%), ICG fluorescence angiography provided information that was supplemental to macroscopic evaluation, but most patients did not survive the postoperative course. However, in six of those cases (11.5%), ICG angiography led to a major change in operative strategy resulting in a significant clinical benefit for those patients. For two cases, ICG fluorescence produced false negative results.Discussion
ICG tissue angiography is feasible and technically reliable for evaluating intestinal perfusion in acute mesenteric ischemia and led to a significant clinical benefit in 11% of our patients. A relevant discrepancy between surgical visual assessment and fluorescence angiography was found in 35% of the cases, which may help to define resection margins more accurately and thus support surgical decision-making.998.
Rehne Lessmann Hansen Bente Lomholt Langdahl Peter Holmberg Jørgensen Klaus Kjær Petersen Kjeld Søballe Maiken Stilling 《Journal of clinical densitometry》2018,21(2):244-251
Visual evaluation of bone changes around an osseointegration (OI) implant in femoral amputees examined on plain radiographs shows that periprosthetic bone resorption takes place during the first years after OI surgery, but the bone mineral density (BMD) change has not been previously quantified by dual-energy X-ray absorptiometry (DXA). Precision is vital when monitoring BMD changes around implants, and thus the aim of this study was to evaluate the precision and feasibility of a scan protocol for BMD measurements in proximity of OI implants. The proximal part of 2 human cadaveric femoral bones (specimens A and B) with OI implants were mounted in a positioning jig and DXA scans were repeated 5 times in increments of 5° from neutral (0°) to 20° flexion and rotation. BMD changes as a result of change in leg position were evaluated. Repeated patient examinations (n?=?20) were conducted in a clinical setting and the precision error was calculated for each of 7 periprosthetic custom-made regions of interest (ROIs). The precision of cadaveric BMD measurements in neutral position was <3.3%. Even 5° flexion or rotation in femur position caused significant changes in average BMD (p?<0.04). Depending on ROI, the percentage of coefficient of variation (%CV) and average BMD was?<6% at 10° flexion and rotation. At 20° flexion, %CV increased up to 12.7% and average BMD increased up to 9.9%. The clinical short-term precision root mean square standard deviation ranged from 0.031?g/cm2 to 0.047?g/cm2 and %CV ranged from 3.12% to 6.57% depending on ROI. Simulated hip flexion or rotation of the femur affected periprosthetic BMD measurements around OI implants in cadaveric femoral bones, which stresses the importance of a reproducible set-up during DXA scans to reduce measurement errors caused by variation in leg position. Adherence to the scan protocol with a relaxed position of the residual limb resulted in an acceptable short-term precision below 6.6%. 相似文献
999.
Daniel W. Lin E. David Crawford Thomas Keane Brent Evans Julia Reid Saradha Rajamani Krystal Brown Alexander Gutin Jonathan Tward Peter Scardino Michael Brawer Steven Stone Jack Cuzick 《Urologic oncology》2018,36(6):310.e7-310.e13
Background
A combined clinical cell-cycle risk (CCR) score that incorporates prognostic molecular and clinical information has been recently developed and validated to improve prostate cancer mortality (PCM) risk stratification over clinical features alone. As clinical features are currently used to select men for active surveillance (AS), we developed and validated a CCR score threshold to improve the identification of men with low-risk disease who are appropriate for AS.Methods
The score threshold was selected based on the 90th percentile of CCR scores among men who might typically be considered for AS based on NCCN low/favorable-intermediate risk criteria (CCR = 0.8). The threshold was validated using 10-year PCM in an unselected, conservatively managed cohort and in the subset of the same cohort after excluding men with high-risk features. The clinical effect was evaluated in a contemporary clinical cohort.Results
In the unselected validation cohort, men with CCR scores below the threshold had a predicted mean 10-year PCM of 2.7%, and the threshold significantly dichotomized low- and high-risk disease (P = 1.2 × 10–5). After excluding high-risk men from the validation cohort, men with CCR scores below the threshold had a predicted mean 10-year PCM of 2.3%, and the threshold significantly dichotomized low- and high-risk disease (P = 0.020). There were no prostate cancer-specific deaths in men with CCR scores below the threshold in either analysis. The proportion of men in the clinical testing cohort identified as candidates for AS was substantially higher using the threshold (68.8%) compared to clinicopathologic features alone (42.6%), while mean 10-year predicted PCM risks remained essentially identical (1.9% vs. 2.0%, respectively).Conclusions
The CCR score threshold appropriately dichotomized patients into low- and high-risk groups for 10-year PCM, and may enable more appropriate selection of patients for AS. 相似文献1000.